Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Erica Zamberletti, Tiziana Rubino, Daniela Parolaro
Pharmacology & Therapeutics (2021) Vol. 226, pp. 107878-107878
Closed Access | Times Cited: 23

Showing 23 citing articles:

Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 146
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
Daryl Efron, Kaitlyn Taylor
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 8, pp. 5430-5430
Open Access | Times Cited: 18
Opportunities, Challenges, and Scientific Progress in Hemp Crops
Kacper Piotr Kaminski, Julia Hoeng, Fernando Goffman, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 7
Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells
Patrícia Alves, Cristina Amaral, Marina Gonçalves, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2971-2984
Open Access | Times Cited: 4
Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (-) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives
Santiago Rodríguez-Carreiro, María Gómez‐Cañas, Francesca Lubrini, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100262-100262
Open Access
Topical Use of Cannabis sativa L. Biochemicals
Léonid Mnekin, Lionel Ripoll
Cosmetics (2021) Vol. 8, Iss. 3, pp. 85-85
Open Access | Times Cited: 25
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela‐Scafati, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 17
Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery
Cindy Santiago-Castañeda, Saúl Huerta de la Cruz, Christopher Martínez-Aguirre, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 16
Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities
Ali Saad, Amal Akour, Abdulla Mahboob, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 612-612
Open Access | Times Cited: 15
Characterization and Biological Activity of Fiber-Type Cannabis sativa L. Aerial Parts at Different Growth Stages
Giulia Mastellone, Arianna Marengo, Barbara Sgorbini, et al.
Plants (2022) Vol. 11, Iss. 3, pp. 419-419
Open Access | Times Cited: 14
Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia
Xue Wang, Cong Lin, Siru Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats
Sara Schiavi, Antonia Manduca, Emilia Carbone, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 6, pp. 897-907
Closed Access | Times Cited: 11
O uso de Cannabis no tratamento do Transtorno do Espectro do Autismo – revisão sistemática
Gabriela Pederiva Engler, Gabriela Almeida Fontes Da Silva, Thiago Macedo Torres, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 1301-1315
Open Access | Times Cited: 2
Accidental Synthetic Cannabinoid Poisoning in a Pediatric Patient: A Case Report
Andrew J Gonedes, Eric Boccio
Cureus (2024)
Open Access | Times Cited: 2
Gut bacteria, endocannabinoid system, and marijuana addiction: Novel therapeutic implications
Kishore Kumar Pinapati, Sree Vidya, Faiz Khan, et al.
Health Sciences Review (2023) Vol. 10, pp. 100144-100144
Open Access | Times Cited: 6
Cannabidivarin alleviates α‐synuclein aggregation via DAF‐16 in Caenorhabditis elegans
Fangru Wang, Ting Jin, Hongyuan Li, et al.
The FASEB Journal (2022) Vol. 37, Iss. 2
Closed Access | Times Cited: 6
Unravelling a novel role for cannabidivarin in the modulation of subventricular zone postnatal neurogenesis
Diogo M. Lourenço, Rita Soares, Sónia Sá Santos, et al.
European Journal of Pharmacology (2023) Vol. 959, pp. 176079-176079
Open Access | Times Cited: 3
Role of polyphenols in epilepsy: from the perspective of gut microbiota
Xiaoxue Xu, Jian Shi, Yinsi Tang, et al.
Deleted Journal (2024)
Open Access
Herbal Medicine Approach and their Effectiveness in the Management of Autism Spectrum Disorders
Samir Abdulkarim Alharbi
Research Journal of Pharmacy and Technology (2024), pp. 3459-3466
Closed Access
Pharmaceutical Applications of Hemp
C. Miyabe Shields, Riley D. Kirk
Springer eBooks (2022), pp. 97-133
Closed Access | Times Cited: 1

Stefano Marini, Lucia D’Agostino, Marika Mentana, et al.
International Journal of Clinical Studies and Medical Case Reports (2023) Vol. 30, Iss. 1
Open Access
Page 1

Scroll to top